Penserra Capital Management LLC Cytom X Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.87 - $7.39 $5,766 - $11,011	-1,490 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.32 - $6.43 $43 - $64	10 Added 0.68%	1,490 $7,000
Q2 2021 Aug 12, 2021	BUY	$6.33 - $9.91 $31 - $49	5 Added 0.34%	1,480 $9,000
Q1 2021 May 13, 2021	BUY	$6.6 - $9.0 $2,739 - $3,735	415 Added 39.15%	1,475 $11,000
Q4 2020 Feb 12, 2021	BUY	$6.47 - $7.9 $4,309 - $5,261	666 Added 169.04%	1,060 $6,000
Q3 2020 Nov 13, 2020	BUY	$6.55 - $8.83 $2,580 - $3,479	394 New	394 $2,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.